GlaxoSmithKline targets growth across units, scraps ViiV listing
GlaxoSmithKline laid out growth targets for its biggest businesses on Wednesday, hoping to convince investors that focusing on consumer health and vaccines would return the drugmaker to long-term growth.
May 06, 2015, 17:28 PM IST